In vitro comparative evaluation of the impact of lacto-N-biose I, a major building block of human milk oligosaccharides, on the fecal microbiota of infants

Anaerobe

Volumn 19, Issue 1, 2013, Pages 50-57

  Satoh, Takumi ^a   Odamaki, Toshitaka ^a   Namura, Mariko ^a   Shimizu, Takashi ^a   Iwatsuki, Keiji ^a   Nishimoto, Mamoru ^b   Kitaoka, Motomitsu ^b   Xiao, Jin zhong ^a  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

Bifidobacterium; Human milk oligosaccharides; Microbiota; Prebiotics; Short chain fatty acids

Indexed keywords

GALACTOSE OLIGOSACCHARIDE; LACTO N BIOSE I; LACTULOSE; MANNANOLIGOSACCHARIDE; OLIGOSACCHARIDE; PREBIOTIC AGENT; RAFFINOSE; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ACIDAMINOCOCCUS; ANALYSIS OF VARIANCE; ARTICLE; ATOPOBIUM; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM BIFIDUM; CENTRIFUGATION; CLOSTRIDIUM; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EUBACTERIUM; FERMENTATION; FUSOBACTERIUM; HUMAN; IN VITRO STUDY; INFANT; MICROFLORA; NONHUMAN; POPULATION DYNAMICS; PREVOTELLA; PRIORITY JOURNAL;

ACETIC ACID; ACETYLGLUCOSAMINE; BIOTA; FECES; HUMANS; INFANT; LACTIC ACID; METAGENOME; MILK, HUMAN;

BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM;

EID: 84872760212     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2012.12.007     Document Type: Article

References (48)

1. German J.B., Dillard C.J., Ward R.E. Bioactive components in milk. Curr Opin Clin Nutr Metab Care 2002, 5:653-658.
2. Harmsen H.J., Wildeboer-Veloo A.C., Raangs G.C., Wagendorp A.A., Klijn N., Bindels J.G., et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000, 30:61-67.
3. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 2006, 136:2127-2130.
4. Coppa G.V., Bruni S., Morelli L., Soldi S., Gabrielli O. The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol 2004, 38:S80-S83.
5. Kiyohara M., Tachizawa A., Nishimoto M., Kitaoka M., Ashida H., Yamamoto K. Prebiotic effect of lacto-N-biose I on bifidobacterial growth. Biosci Biotechnol Biochem 2009, 73:1175-1179.
6. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 2000, 20:699-722.
7. Ward R.E., Ninonuevo M., Mills D.A., Lebrilla C.B., German J.B. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res 2007, 51:1398-1405.
8. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad Ser B Phys Biol Sci 2010, 86:731-747.
9. Shen Q., Tuohy K.M., Gibson G.R., Ward R.E. In vitro measurement of the impact of human milk oligosaccharides on the faecal microbiota of weaned formula-fed infants compared to a mixture of prebiotic fructooligosaccharides and galactooligosaccharides. Lett Appl Microbiol 2011, 52:337-343.
10. Kitaoka M., Tian J., Nishimoto M. Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl Environ Microbiol 2005, 71:3158-3162.
11. Nishimoto M., Kitaoka M. Identification of N-acetylhexosamine 1-kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum. Appl Environ Microbiol 2007, 73:6444-6449.
12. Derensy-Dron D., Krzewinski F., Brassart C., Bouquelet S. Beta-1,3-galactosyl-N-acetylhexosamine phosphorylase from Bifidobacterium bifidum DSM 20082: characterization, partial purification and relation to mucin degradation. Biotechnol Appl Biochem 1999, 29:3-10.
13. Wada J., Ando T., Kiyohara M., Ashida H., Kitaoka M., Yamaguchi M., et al. Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl Environ Microbiol 2008, 74:3996-4004.
14. Fujita K., Oura F., Nagamine N., Katayama T., Hiratake J., Sakata K., et al. Identification and molecular cloning of a novel glycoside hydrolase family of core 1 type O-glycan-specific endo-N-acetylgalactosaminidase from Bifidobacterium longum. J Biol Chem 2005, 280:37415-37422.
15. Katayama T., Fujita K., Yamamoto K. Novel bifidobacterial glycosidases acting on sugar chains of mucin glycoproteins. J Biosci Bioeng 2005, 99:457-465.
16. Katayama T., Wada J., Fujita K., Kiyohara M., Ashida H., Yamamoto K. Functions of novel glycosidases isolated from bifidobacteria. J Appl Glycosci 2008, 55:101-109.
17. Xiao J.Z., Takahashi S., Nishimoto M., Odamaki T., Yaeshima T., Iwatsuki K., et al. Distribution of in vitro fermentation ability of lacto-N-biose I, a major building block of human milk oligosaccharides, in bifidobacterial strains. Appl Environ Microbiol 2010, 76:54-59.
18. Asano I., Hamaguchi K., Fujii S., Iino H. In vitro digestibility and fermentation of mannooligosaccharides from coffee mannan. Food Sci Technol Res 2003, 9:62-66.
19. Asano I., Nakamura Y., Hoshino H., Aoki K., Fujii S., Imura N., et al. Use of mannooligosaccharides from coffee mannan by intestinal bacteria. Nippon Nogeikagaku Kaishi 2001, 75:1077-1083.
20. De Preter V., Vanhoutte T., Huys G., Swings J., Rutgeerts P., Verbeke K. Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. Aliment Pharmacol Ther 2006, 23:963-974.
21. Dinoto A., Marques T.M., Sakamoto K., Fukiya S., Watanabe J., Ito S., et al. Population dynamics of Bifidobacterium species in human feces during raffinose administration monitored by fluorescence in situ hybridization-flow cytometry. Appl Environ Microbiol 2006, 72:7739-7747.
22. Rastall B. Prebiotics. Chemical and functional properties of food components 2007, 391-411. CRC Press, New York. Z.E. Sikorski (Ed.).
23. Matsuki T, Fujimoto J, Watanabe K. Japan Patent Kokai 2007; P2007-20423A.
24. Matsuki T., Watanabe K., Fujimoto J., Takada T., Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 2004, 70:7220-7228.
25. Matsuki T., Watanabe K., Fujimoto J., Miyamoto Y., Takada T., Matsumoto K., et al. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002, 68:5445-5451.
26. Matsuki T., Watanabe K., Fujimoto J., Kado Y., Takada T., Matsumoto K., et al. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 2004, 70:167-173.
27. Namba K, Hatano M, Yaeshima T, Ishibashi N, Tamura Y. Method of detecting Bifidobacterium infantis. International Patent 2005; WO2005/080563.
28. Matsuda K., Tsuji H., Asahara T., Kado Y., Nomoto K. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 2007, 73:32-39.
29. Delroisse J.M., Boulvin A.L., Parmentier I., Dauphin R.D., Vandenbol M., Portetelle D. Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR. Microbiol Res 2008, 63:663-670.
30. Nishimoto M., Kitaoka M. Practical preparation of lacto-N-biose I, a candidate for the bifidus factor in human milk. Biosci Biotechnol Biochem 2007, 71:2101-2104.
31. Yaeshima T., Takahashi S., Matsumoto N., Ishibashi N., Hayasawa H., Iino H. Effect of yogurt containing Bifidobacterium longum BB536 on the intestinal environment, fecal characteristics and defecation frequency: a comparison with standard yogurt. Biosci Microflora 1997, 16:73-77.
32. Rossi M., Corradini C., Amaretti A., Nicolini M., Pompei A., Zanoni S., et al. Fermentation of fructooligosaccharides and insulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol 2005, 71:6150-6158.
33. Abe F., Muto M., Yaeshima T., Iwatsuki K., Aihara H., Ohashi Y., et al. Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability. Anaerobe 2010, 16:131-136.
34. Ohmomo S., Tanaka O., Kuze-Kitamoto H. Analysis of organic acids in silage by high-performance liquid chromatography. Bull Natl Grassland Res Inst 1993, 48:51-56.
35. Knol J., Scholtens P., Kafka C., Steenbakkers J., Gro S., Helm K., et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 2005, 40:36-42.
36. Matsuki T., Watanabe K., Tanaka R., Fukuda M., Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 1999, 65:4506-4512.
37. He F., Ouwehand A.C., Isolauri E., Hashimoto H., Benno Y., Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2000, 30:43-47.
38. He F., Morita H., Ouwehand A.C., Hosoda M., Hiramatsu M., Kurisaki J., et al. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol 2002, 46:781-785.
39. Khailova L., Mount Patrick S.K., Arganbright K.M., Halpern M.D., Kinouchi T., Dvorak B. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010, 299:G1118-G1127.
40. Asakuma S., Hatakeyama E., Urashima T., Yoshida E., Katayama T., Yamamoto K., et al. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J Biol Chem 2011, 286:34583-34592.
41. Darzi J., Frost G.S., Robertson M.D. Do SCFA have a role in appetite regulation?. Proc Nutr Soc 2011, 70:119-128.
42. Miyauchi S., Hirasawa A., Ichimura A., Hara T., Tsujimoto G. New frontiers in gut nutrient sensor research: free fatty acid sensing in the gastrointestinal tract. J Pharmacol Sci 2010, 112:19-24.
43. Ohata A., Usami M., Miyoshi M. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation. Nutrition 2005, 21:838-847.
44. Fukuda S., Toh H., Hase K., Oshima K., Nakanishi Y., Yoshimura K., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
45. Tsukahara T., Ushida K. Organic acid profiles in feces of pigs with pathogenic or non-pathogenic diarrhea. J Vet Med Sci 2011, 63:1351-1354.
46. Macfarlane S., Macfarlane G.T. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003, 62:67-72.
47. Sato T., Matsumoto K., Okumura T., Yokoi W., Naito E., Yoshida Y., et al. Isolation of lactate-utilizing butyrate-producing bacteria from human feces and in vivo administration of Anaerostipes caccae strain L2 and galacto-oligosaccharides in a rat model. FEMS Microbiol Ecol 2008, 66:528-536.
48. Falony Gwen, Vlachou Angeliki, Verbrugghe Kristof, De Vuyst Luc Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 2006, 72:7835-7841.